Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.
Also called NCT07658807
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT07658807
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07658807. Randomized; no masking; primary purpose prevention. Start 2026-06 (anticipated); primary completion 2028-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease
- Condition
- Peripheral Arterial Disease
- Condition
- Diabetic Angiopathies
- Condition
- Arterial Occlusive Diseases
- Intervention (Drug)
- Hua Yu Wan Capsule
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Xuanwu Hospital, Beijing
- Collaborator
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Collaborator
- Dongzhimen Hospital, Beijing
- Collaborator
- Peking University Third Hospital
Record details
- Record id
cardio:ct-nct07658807- Content hash
8cb6e324dad0c0ff227fa5360f69e1dc7b3f1117ebd34551de16113f09d5b966